Chemours (CC) PT Lowered to $18 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $15.91 +3.18%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Morgan Stanley analyst Vincent Andrews lowered the price target on Chemours (NYSE: CC) to $18.00 (from $21.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
- Keysight Technologies (KEYS) PT Raised to $440 at UBS Amid Broad-Based AI Strength
- Legence Corp (LGN) PT Raised to $130 at Tigress Financial Partners
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
